Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Tay-Sachs disease is a rare, inherited metabolic disorder caused by mutations in the HEXA gene, which prevents the body from producing a vital enzyme called beta-hexosaminidase A. Without this enzyme, a fatty substance known as GM2 ganglioside accumulates to toxic levels in nerve cells, leading to the progressive neurological damage characteristic of Tay-Sachs disease. What causes Tay-Sachs disease at the genetic level? The root cause of Tay-Sachs disease is a specific genetic mutation on chromosome 15 (15q23).
TL;DR: Tay-Sachs disease is a rare, inherited metabolic disorder caused by mutations in the HEXA gene, which prevents the body from producing a vital enzyme called beta-hexosaminidase A. Without this enzyme, a fatty substance known as GM2 ganglioside accumulates to toxic levels in nerve cells, leading to the progressive neurological damage characteristic of Tay-Sachs disease.
The root cause of Tay-Sachs disease is a specific genetic mutation on chromosome 15 (15q23). Humans typically have two working copies of the HEXA gene, which provide instructions to create the beta-hexosaminidase A enzyme. In individuals with Tay-Sachs disease, both copies of the gene are mutated. Think of the HEXA gene as a blueprint for a "cleanup crew" in the brain; if the blueprint is faulty, the crew cannot break down waste products, leading to a buildup that destroys neurons.
Yes, Tay-Sachs disease follows an autosomal recessive inheritance pattern. This means that for a child to be born with the condition, both parents must be carriers of a HEXA mutation. When both parents are carriers, there is a 25% chance with each pregnancy that the child will inherit the disease. There are no environmental triggers or external factors that cause Tay-Sachs disease; it is determined entirely at the moment of conception.
The pathophysiology of Tay-Sachs disease involves the lysosome, the cell’s "recycling center." The following steps outline the metabolic failure:
Researchers are actively investigating gene therapy and enzyme replacement techniques to restore HEXA function. While the cause of Tay-Sachs disease is fully understood, scientists are focused on finding ways to bypass the blood-brain barrier to deliver functional enzymes or genetic material directly to the central nervous system to halt the progression of the disease.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.